Cellect Biotechnology Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on March 18, 2019, by Cellect Biotechnology Ltd. (a foreign private issuer based in Kfar Saba, Israel), incorporates by reference a press release dated March 18, 2019. The filing announces the company's Fourth Quarter and Full Year 2018 financial results and outlines recent corporate progress.
Key Financial Metrics
The provided text serves as a cover sheet and does not contain specific numerical data. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity for the reported period.
Material Changes
Specific material changes versus the prior comparable period are not detailed in the cover document. The filing indicates that such details are contained within the attached Exhibit 99.1 press release, which is not included in the input text.
Guidance, Outlook, and Risks
The filing references "Recent Corporate Progress" in the title of the incorporated press release but does not provide specific guidance, outlook, management commentary, risks, contingencies, or unusual items in the text provided.
Investor Verification Checklist
- Verify the specific Q4 and Full Year 2018 financial figures (revenue, net loss, cash position) in the attached Exhibit 99.1 press release.
- Confirm the details of the "Recent Corporate Progress" mentioned in the filing title.
- Review the full press release for any updated guidance or risk factors not summarized in this cover sheet.
- Note that the registrant files annual reports on Form 20-F.